航天發展(000547.SZ):2021年年報延期至4月26日披露
格隆匯3月25日丨航天發展(000547.SZ)公佈,公司原定於2022年3月31日披露2021年年度報吿。因受新冠肺炎疫情及部分地區疫情防控措施影響,公司2021年度審計工作和2021年年度報吿編制工作未能按預期完成,公司預計無法按照原計劃時間披露2021年年度報吿。
本着審慎原則及對廣大投資者負責的態度,同時為確保2021年年度報吿的質量和信息披露的準確性,經向深圳證券交易所申請,公司2021年年度報吿延期至2022年4月26日披露。公司董事會對此次調整年度報吿披露時間給投資者帶來的不便致以誠摯的歉意,敬請廣大投資者諒解。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.